Financial giants have made a conspicuous bearish move on Bristol-Myers Squibb ( BMY ). Our analysis of options history for Bristol-Myers Squibb ( BMY ) revealed 8 unusual trades.

Delving into the details, we found 37% of traders were bullish, while 62% showed bearish tendencies. Out of all the trades we spotted, 3 were puts, with a value of $222,715, and 5 were calls, valued at $303,050.

Projected Price Targets

After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $39.0 and $49.0 for Bristol-Myers Squibb ( BMY ), spanning the last three months.

Volume & Open Interest Trends

Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Bristol-Myers Squibb's ( BMY ) options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Bristol-Myers Squibb's ( BMY ) substantial trades, within a strike price spectrum from $39.0 to $49.0 over the preceding 30 days.

Bristol-Myers Squibb Option Activity Analysis: Last 30 Days

Largest Options Trades Observed:

About Bristol-Myers Squibb

Bristol-Myers Squibb ( BMY ) discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.

Following our analysis of the options activities associated with Bristol-Myers Squibb ( BMY ), we pivot to a closer look at the company's own performance.

Bristol-Myers Squibb's Current Market Status

With a trading volume of 2,060,715, the price of BMY is down by -1.53%, reaching $40.67.

Current RSI values indicate that the stock is is currently neutral between overbought and oversold.

Next earnings report is scheduled for 24 days from now.

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.

If you want to stay updated on the latest options trades for Bristol-Myers Squibb ( BMY ), Benzinga Pro gives you real-time options trades alerts.